Stewart Bates
- Oncology top 1%
- Cancer-related Molecular Pathways 16
- CAR-T cell therapy research 2
- Biotechnology top 1%
- Cancer Research and Treatments 7
- Molecular Biology top 5%
- Cell death mechanisms and regulation 3
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 2
- Cancer Research top 5%
- Cell Biology top 5%
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Karen H. VousdenGodefridus J. PetersDavid ParryAndrew C. PhillipsKevin M. RyanDavid J. MannRobert L. LudwigÉva Bálint
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Stewart Bates
18 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 98
- Oncology 2.2k
- Biotechnology 500
- Molecular Biology 2.2k
- Cancer Research 438
- Cell Biology 359
Countries citing papers authored by Stewart Bates
This map shows the geographic impact of Stewart Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stewart Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stewart Bates more than expected).
Fields of papers citing papers by Stewart Bates
This network shows the impact of papers produced by Stewart Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stewart Bates. The network helps show where Stewart Bates may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stewart Bates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 204 | |
| 2 | 1999 | 261 | |
| 3 | 1999 | 186 | |
| 4 | 1999 | 14 | |
| 5 | 1998 | 149 | |
| 6 | 1997 | 237 | |
| 7 | 1997 | 89 | |
| 8 | 1997 | 42 | |
| 9 | Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2. | 1997 | 3 |
| 10 | 1996 | 228 | |
| 11 | 1996 | 306 | |
| 12 | 1996 | 259 | |
| 13 | 1995 | 93 | |
| 14 | Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. | 1995 | 155 |
| 15 | 1995 | 313 | |
| 16 | Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. | 1994 | 162 |
| 17 | CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. | 1994 | 229 |
| 18 | 1984 | 23 |
About Stewart Bates
Stewart Bates is a scholar working on Biotechnology, Oncology and Ophthalmology, having authored 18 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (16 papers), Cancer Research and Treatments (7 papers), Cell death mechanisms and regulation (3 papers), Ubiquitin and proteasome pathways (3 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers), Advanced Breast Cancer Therapies (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (2.2k citations), Biotechnology (500 citations) and Molecular Biology (2.2k citations). Stewart Bates has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Karen H. Vousden, Godefridus J. Peters, David Parry, Andrew C. Phillips, Kevin M. Ryan, David J. Mann, Robert L. Ludwig, Éva Bálint, Laura Bonetta and Clive Dickson. Their work appears in journals such as Oncogene, The EMBO Journal, Genes & Development, Molecular Carcinogenesis and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.